Study summary

Weekly adalimumab ranked highest among approved-era biologics

Biologics comparison · Phase 3 trials, pooled · Published March 2025, Journal of the European Academy of Dermatology and Venereology

What was tested

A network meta-analysis comparing phase 3 trials of biologics for hidradenitis suppurativa at 12 to 16 weeks.

What they found

Weekly adalimumab ranked most effective at reaching a 50% response, ahead of secukinumab every 2 weeks.
Differences between most biologics were small.

What it means

Several biologics work similarly; choice depends on access, dosing and other conditions.

J Eur Acad Dermatol Venereol, via PubMed ↗ ← Back to the outlook

Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.